Foetal gluten immunogenic peptides during pregnancy: a new determinant on the coeliac exposome

The increasing incidence of coeliac disease is leading to a growing interest in active search for associated factors, even the intrauterine and early life. The exposome approach to disease encompasses a life course perspective from conception onwards has recently been highlighted. Knowledge of early exposure to gluten immunogenic peptides (GIP) in utero could challenge the chronology of early prenatal tolerance or inflammation, rather than after the infant’s solid diet after birth.

¿Te ha gustado la entrada? Compártela

Foetal gluten immunogenic peptides during pregnancy: a new determinant on the coeliac exposome

Menú

Datos de contacto

Síguenos

Avisos legales